Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | nitroreductase A, NADPH-dependent, FMN-dependent | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium ulcerans | hypothetical protein | Get druggable targets OG5_137372 | All targets in OG5_137372 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.2162 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0246 | 0 | 0.5 |
Trichomonas vaginalis | ribokinase, putative | 0.0246 | 0 | 0.5 |
Entamoeba histolytica | tagatose-6-phosphate kinase, putative | 0.0246 | 0 | 0.5 |
Trypanosoma cruzi | adenosine kinase, putative | 0.2162 | 1 | 1 |
Onchocerca volvulus | 0.1916 | 0.8714 | 1 | |
Echinococcus multilocularis | adenosine kinase | 0.2162 | 1 | 1 |
Mycobacterium leprae | Probable adenosine kinase adk | 0.0246 | 0 | 0.5 |
Giardia lamblia | Ribokinase | 0.0246 | 0 | 0.5 |
Entamoeba histolytica | Hypothetical protein T24C12.3, putative | 0.0246 | 0 | 0.5 |
Mycobacterium tuberculosis | Adenosine kinase | 0.0246 | 0 | 0.5 |
Trichomonas vaginalis | ribokinase, putative | 0.0246 | 0 | 0.5 |
Mycobacterium tuberculosis | Ribokinase RbsK | 0.0246 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.1589 | 0.7008 | 0.7008 |
Entamoeba histolytica | fructokinase, putative | 0.0246 | 0 | 0.5 |
Trypanosoma brucei | adenosine kinase, putative | 0.2162 | 1 | 1 |
Trypanosoma brucei | adenosine kinase, putative | 0.2162 | 1 | 1 |
Toxoplasma gondii | kinase, pfkB family protein | 0.2162 | 1 | 1 |
Trichomonas vaginalis | ribokinase, putative | 0.0246 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.1604 | 0.7088 | 1 |
Entamoeba histolytica | kinase, PfkB family | 0.0246 | 0 | 0.5 |
Entamoeba histolytica | ribokinase, putative | 0.0246 | 0 | 0.5 |
Schistosoma mansoni | adenosine kinase | 0.2162 | 1 | 1 |
Leishmania major | adenosine kinase, putative | 0.2162 | 1 | 1 |
Trypanosoma brucei | RNA helicase, putative | 0.1589 | 0.7008 | 0.7008 |
Trypanosoma cruzi | adenosine kinase, putative | 0.2162 | 1 | 1 |
Echinococcus granulosus | adenosine kinase | 0.2162 | 1 | 1 |
Mycobacterium tuberculosis | 6-phosphofructokinase PfkB (phosphohexokinase) (phosphofructokinase) | 0.0246 | 0 | 0.5 |
Schistosoma mansoni | adenosine kinase | 0.2162 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Hypersensitivity factor (functional) | = 1.8 | Potency in clonogenic assay defined by Hypersensitivity factor calculated for AA8 cells versus EMT6 cells [IC50(AA8)/IC50 (EMT6)] | ChEMBL. | 8691449 |
Hypersensitivity factor (functional) | = 4.9 | Potency in clonogenic assay, defined by hypersensitivity factor calculated for UV4 cells versus AA8 cells [IC50(AA8)/IC50(UV4)] | ChEMBL. | 8691449 |
IC50 (functional) | = 13 uM | Cytotoxicity in T79-A3 (NR-positive) cell lines | ChEMBL. | 9111301 |
IC50 (functional) | = 13 uM | Cytotoxicity in T79-A3 (NR-positive) cell lines | ChEMBL. | 9111301 |
IC50 (functional) | = 500 uM | Inhibition of growth under aerobic conditions in AA8 cells | ChEMBL. | 8691449 |
IC50 (functional) | = 919 uM | Cytotoxicity in T78-1 (NR-negative) cell lines | ChEMBL. | 9111301 |
Ratio (functional) | = 75 | IC50 ratio for NR-positive and NR-negative cell lines | ChEMBL. | 9111301 |
Ratio (functional) | = 75 | IC50 ratio for NR-positive and NR-negative cell lines | ChEMBL. | 9111301 |
TE50 (functional) | = 12 | TE50 is termed as Bystander effect evaluated in T78-1 and T79-A3 cell lines | ChEMBL. | 9111301 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.